Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
Saved in:
| Title: | Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness. |
|---|---|
| Authors: | Mongiardi MP; Institute of Biochemistry and Cell Biology, IBBC-CNR, Monterotondo, Rome, Italy., Pallini R; Department of Neuroscience, Neurosurgery Section, Università Cattolica del Sacro Cuore, Rome, Italy., D'Alessandris QG; Department of Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy., Levi A; Institute of Biochemistry and Cell Biology, IBBC-CNR, Monterotondo, Rome, Italy., Falchetti ML; Institute of Biochemistry and Cell Biology, IBBC-CNR, Monterotondo, Rome, Italy. |
| Source: | Expert reviews in molecular medicine [Expert Rev Mol Med] 2024 Apr 02; Vol. 26, pp. e5. Date of Electronic Publication: 2024 Apr 02. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Published by Cambridge University Press in association with the Clinical and Biomedical Computing Unit of the University of Cambridge School of Clinical Medicine Country of Publication: England NLM ID: 100939725 Publication Model: Electronic Cited Medium: Internet ISSN: 1462-3994 (Electronic) Linking ISSN: 14623994 NLM ISO Abbreviation: Expert Rev Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1462-3994 |
|---|---|
| DOI: | 10.1017/erm.2024.8 |
